📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Repair of Acute Respiratory Distress Syndrome in COVID-19 by Stromal Cells (REALIST-COVID Trial): A Multicenter, Randomized, Controlled Clinical Trial. (2023)

First Author: Gorman EA

Attributed to: A GMP cell therapy facility to test cell based therapies funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1164/rccm.202302-0297oc

PubMed Identifier: 37154608

Publication URI: http://europepmc.org/abstract/MED/37154608

Type: Journal Article/Review

Volume: 208

Parent Publication: American journal of respiratory and critical care medicine

Issue: 3

ISSN: 1073-449X